• • Catalog Number:

    E1A0101L-1

  • Amount:

    30ul

  • Form of Antibody:

    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

  • Storage/Stability:

    Store at -20℃/1 year

  • class="eg_cn_title"Immunogen:

    The antiserum was produced against synthesized peptide derived from human Aggrecan.

  • Purification:

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

  • Reactivity:

    Human, Rat

  • SwissProtNo:

    P16112

  • Applications:

    WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:20000

  • Alter Name:

    CSPG1, CSPGCP, MSK16, CHONDROITIN SULFATE PROTEOGLYCAN CORE PROTEIN 1, aggrecan 1 (chondroitin sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified by monoclonal antibody A0122), aggrecan 1 isoform 1 precursor, aggrecan 1 isoform 2 precursor, cartilage-specific proteoglycan core protein

  • Specificity Sensitivity:

    Aggrecan (Cleaved-Asp369) antibody detects endogenous levels of fragment of activated Aggrecan resulting from cleavage adjacent to Asp369.

  • References:

    Ichiro Sekiya, J. Biol. Chem., Apr 2000; 275: 10738. Ying Liu, J. Biol. Chem., Nov 1997; 272: 29880. Russell T. Matthews, J. Neurosci., Sep 2002; 22: 7536. Amit Agrawal, Am J Physiol Cell Physiol, Apr 2007; 10.1152

  • All Sites:

    Human: Asp369; Rat: Asp369

Cl-Peptide - + Immunohistochemical analysis of paraffin-embedded human lung carcinoma tissue using Aggrecan (Cleaved-Asp369) antibody (#L0101).

Western blot analysis of extracts from Jurkat cells, treated with Etoposide (25uM, 60mins), using Aggrecan (Cleaved-Asp369) antibody (#L0101).